|
Post by sportsrancho on Oct 15, 2016 10:01:45 GMT -5
|
|
|
Post by centralcoastinvestor on Oct 15, 2016 10:18:21 GMT -5
More people saw the Time Magazine ads than people will at the MLB. Prints should be used as complimentary ads, not as a primary marketing campaign. SNY ads were crap. So more people saw crap ads in Time. At least these ads differentiate Afrezza as being a very unique insulin. And this isn't the only part if their campaign. Much of the Mnkd campaign so far has been focused on educating Endos and diabetes educators about the product. There isn't a lot of advertising money but it is what is.
|
|
|
Post by gamblerjag on Oct 15, 2016 10:40:49 GMT -5
which seems to be a PATTERN for Mike C.
|
|
|
Post by fiddler on Oct 15, 2016 10:44:31 GMT -5
The bad thing about print ads is so much of the page is necessarily devoted to "bad" stuff. You're, in effect, spending around two thirds of your advertising dollar to advertise warnings, black boxes, and adverse effects. It's interesting that, presumably as a consequence of my researching afrezza, nearly every website I go to has an ad either for Dexcom or for januvia. They are small but now I'm seeing flashing green januvia ads 20-30 times a day and with practically no accompanying warnings. And here is a slew of articles about what other companies have done using social media: www.simplyzesty.com/blog/article/march-2013/50-social-media-case-studies-you-should-bookmarkRelatively inexpensive and likely a million workarounds to avoid saying too much about "bad" stuff. All that said, insurance coverage improvement needs to be the primary goal. Until that's better, any advertising is practically a waste.
|
|
|
Post by liane on Oct 15, 2016 10:55:33 GMT -5
The bad thing about print ads is so much of the page is necessarily devoted to "bad" stuff. You're, in effect, spending around two thirds of your advertising dollar to advertise warnings, black boxes, and adverse effects... And the funny thing about your posts is that most of them are devoted to the "bad" stuff. You're, in effect, spending around two thirds of your posts to reiterate warnings, black boxes, and adverse effects... What's with that?
|
|
|
Post by dictatorsaurus on Oct 15, 2016 11:05:06 GMT -5
The bad thing about print ads is so much of the page is necessarily devoted to "bad" stuff. You're, in effect, spending around two thirds of your advertising dollar to advertise warnings, black boxes, and adverse effects... And the funny thing about your posts is that most of them are devoted to the "bad" stuff. You're, in effect, spending around two thirds of your posts to reiterate warnings, black boxes, and adverse effects... What's with that? fiddler is expressing his personal opinion on an online forum. The warnings are plastered all over ads which are printed for the sole purpose of promoting and selling the product to the public/patients. Big difference between the two.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 15, 2016 11:05:53 GMT -5
Unlike Time or People that are tossed out after a period of time, playoff game books are saved. There is logic Castagna's marketing decision. Hopefully, the ads are placed during the Cubs playoffs. Imagine if it is and the Cubs win??? I will try to drive to Wrigley field today and scan one.
|
|
|
Post by audiomr on Oct 15, 2016 11:44:06 GMT -5
A well-designed ad. Eye tends to go naturally to the top of the right-hand page, so the sell copy is there. Graphic at the top left leads to the top right. All the cautionary stuff is at the bottom.
|
|
|
Post by lakers on Oct 15, 2016 20:52:57 GMT -5
|
|
|
Post by mnkdfann on Oct 16, 2016 0:48:08 GMT -5
They really should have stuck a baseball glove on Outsulin's hand, and given him a bat to carry.
But I suppose the cash situation didn't allow for any changes to previously done Outsulin artwork.
|
|
|
Post by esstan2001 on Oct 16, 2016 9:04:29 GMT -5
They really should have stuck a baseball glove on Outsulin's hand, and given him a bat to carry. But I suppose the cash situation didn't allow for any changes to previously done Outsulin artwork. Put the bat in Insulin's hands, hitting one where Outsulin catches it, and the umpire yells, 'YOUR OUT !!!'
|
|
|
Post by nimrod71 on Oct 16, 2016 9:21:09 GMT -5
So like 40000 people at the game maybe a third actually buy the program, and then it only pertains to a few that bought it.
|
|
|
Post by nimrod71 on Oct 16, 2016 9:26:49 GMT -5
I guess it's better than nothing. I think that guy who posted no mass marketing equals no mass sales is right.
|
|
|
Post by brotherm1 on Oct 16, 2016 9:54:26 GMT -5
I guess it's better than nothing. I think that guy who posted no mass marketing equals no mass sales is right. If you are not part of the solution, you are part of the problem. Get your head out of the sand and come up with construction.
|
|
|
Post by mnholdem on Oct 16, 2016 9:56:45 GMT -5
Diseases and medical conditions are more likely to be treated when consumers see DTC prescription drug ads.
According to a 2004 FDA survey, 88% of the physicians who had patients ask about drugs seen in DTC ads reported that the patients had the conditions the drugs treat and were thus able to get treatment. For example, Procrit is a drug used to counteract anemia and can be used to help chemotherapy patients with fatigue. Prior to an ad campaign for the drug, it was rarely prescribed because chemotherapy patients were not reporting fatigue caused by the chemotherapy to their doctors. After seeing the ad, however, patients reported fatigue and could be appropriately diagnosed. In 2007 the FDA approved a drug for fibromyalgia, a condition that previously had no drug treatment, so patients with the condition were made aware of a possible treatment through DTC prescription drug ads and could speak to their doctors in order to receive treatment.
Source: prescriptiondrugs.procon.org--- Over the summer, the FDA conducted the conference that some entitled "Beyond a1C" which enlightened so many HCPs and PWDs to the fact that there are measurements which are much more accurate and useful than a1C. The INsulin / OUTsulin campaign is capitalizing on this trend to better understand diabetes treatment. As the FDA survey (above) illustrates, many patients may not ask for a Afrezza until they are made aware of this treatment through DTC drug advertisements.
|
|